ONAPGO™ (apomorphine HCL) injection, for subcutaneous use 4.9 …
ONAPGO (apomorphine HCL) injection, for sc infusion is a continuous treatment of motor fluctuations (OFF episodes) in Parkinson’s disease patients.
See results only from onapgo.comFull Prescribing Information
ONAPGO is a dopaminergic agonist indicated for the treatment of motor …
Instructions for Use
ONAPGO is a prescription medicine used to treat motor fluctuations in adults with …
ONAPGO is a dopaminergic agonist indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. (1) The extra dose may be titrated in increments of 0.5 mg or 1 …
ONAPGO is a prescription medicine used to treat motor fluctuations in adults with advanced Parkinson’s disease (PD). Only use the ONAPGO Infusion Pump if you have received …
ONAPGO: A Newly-Approved Medication for OFF Periods in …
Feb 5, 2025 · ONAPGO TM: A Newly-Approved Medication for OFF Periods in Parkinson’s. Breaking News! The first subcutaneous (under the skin) apomorphine infusion, now called …
Onapgo (apomorphine) - Uses, Side Effects, and More
6 days ago · Overview: Onapgo is used to treat certain symptoms of Parkinson’s disease. It is an injectable medicine given under your skin as a continuous infusion using a pump. Onapgo is …
SPN-830, now Onapgo, approved for advanced Parkinson’s disease
Feb 4, 2025 · Previously called SPN-830, Onapgo consists of a portable electronic pump that continuously delivers apomorphine via a subcutaneous infusion over 14-18 hours a day. This …
FDA Approves Onapgo - Drugs.com
Before you start using Onapgo, tell your healthcare provider about all of your medical conditions, including: difficulty staying awake during the daytime • dizziness, fainting spells, or low blood …
Onapgo (apomorphine hydrochloride infusion) | Parkinson's Disease
Because Onapgo is delivered continuously through an under-the-skin infusion, the medication bypasses the gastrointestinal track and directly enters the brain, stimulating dopamine …
FDA Approves First Subcutaneous Apomorphine Device for …
Feb 4, 2025 · Onapgo, a subcutaneous apomorphine infusion device, is approved for advanced Parkinson's disease, offering continuous symptom management without surgery. The …
Supernus Announces FDA Approval of ONAPGO™ (apomorphine …
Feb 4, 2025 · ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s disease; ONAPGO is a …
